Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro is not known to cause vaginal spotting directly. It does not act on reproductive hormones, and spotting is not listed as a recognised side effect in its Summary of Product Characteristics. That said, several indirect mechanisms can make spotting on Mounjaro a real experience for some women, and understanding why matters before you decide how to respond. These are prescription-only medicines, and any change to your menstrual pattern worth worrying about deserves a clinical conversation rather than a self-diagnosis.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
If you started spotting shortly after beginning Mounjaro, or after a dose increase, and you take a combined oral contraceptive, this is the first thing worth considering. Mounjaro slows gastric emptying, the rate at which your stomach moves its contents into the small intestine. Oral medicines absorbed in the gut, including the pill, may pass through more slowly, and absorption can be inconsistent, particularly in the early weeks.
NHS guidance specifically advises women on oral contraceptives to use a non-oral method of contraception (condoms, for example) for the first four weeks of Mounjaro treatment and for four weeks after each dose increase. This recommendation exists precisely because reduced pill absorption can affect both contraceptive reliability and cycle regularity. Breakthrough bleeding or spotting is a recognised consequence of inconsistent pill levels. If you have not been following this guidance, irregular bleeding is a predictable result rather than a mystery.
The NHS England guidance on weight-management injections covers this clearly, and it is worth reading if you are currently on hormonal contraception. Switching to a non-oral method (a patch, ring, implant, injection or coil) removes the absorption uncertainty entirely. Talk to your GP or prescriber about the right option for you. Our overview of Mounjaro covers more on the drug's mechanisms if you want the background.
Here is the part that often surprises people. Rapid or significant fat loss changes how your body produces and processes oestrogen. Adipose (fat) tissue is hormonally active, it contributes to circulating oestrogen levels. When fat stores fall quickly, oestrogen can drop temporarily, and the hypothalamic-pituitary-ovarian axis that governs your cycle is sensitive to that kind of shift.
The result can be a lighter period, a missed period, mid-cycle spotting, or irregular timing. This is not a Mounjaro side effect in the direct pharmacological sense; it is a consequence of successful weight loss. The same phenomenon occurs with rapid weight loss from surgery, a very-low-calorie diet, or intensive exercise. It tends to settle as body weight stabilises.
If spotting starts weeks or months into treatment rather than within the first days, and you are not on oral contraceptives, this metabolic pathway is the more likely explanation. It does not mean anything is wrong with your reproductive system, though it does mean your body is changing. If you are also experiencing other unexpected symptoms alongside weight loss, the picture is worth discussing with a clinician rather than attributing everything to one cause.
Most spotting linked to contraceptive absorption or early weight-loss hormonal changes settles on its own or resolves once you adjust contraception. But spotting is not always benign, and Mounjaro does not make someone immune to gynaecological conditions that need investigation.
You should speak to a GP promptly if: spotting is heavy or prolonged; you have pelvic pain alongside it; it occurs after sex; it continues beyond two or three cycles; or you are post-menopausal. These are not Mounjaro red flags specifically, they are red flags for uterine, cervical or ovarian pathology that requires investigation regardless of what medicine you are taking.
It is also worth knowing that if you are experiencing significant gastrointestinal symptoms (which the NHS patient information for tirzepatide lists as among the most common Mounjaro side effects) nausea and vomiting can themselves disrupt oral contraceptive absorption, adding another layer to the cycle disruption picture. Some people also wonder whether Mounjaro causes wind and bloating, and how those digestive effects interact with daily life on treatment, and there is related detail on whether Mounjaro causes gas for anyone noticing that particular symptom alongside their other side effects.
You are likely reading this because you noticed something unexpected and want to know whether to worry. That is a reasonable place to be. The honest answer is: probably not, but the right move depends on your contraception, how far into treatment you are, and whether any other symptoms are present.
If you use the pill, act on the contraception advice above immediately, switch to a backup method and raise it with whoever prescribed your Mounjaro. If you are not on hormonal contraception and the spotting is mild and recent, it is worth monitoring for a cycle or two while noting whether it correlates with dose changes or rapid weight movement. If it persists, see a GP.
For context on the cost and structure of private treatment before booking anything, the treatment page sets out what is included in full. People also sometimes ask whether Mounjaro causes erectile dysfunction, which is a separate question with its own answer worth reading if it is relevant to you. And if you have questions about skin changes rather than bleeding, there is separate information on whether Mounjaro causes spots on the skin. Different query, different answer. When you are ready to speak to someone clinically, start your consultation with our prescribers, a real clinician reviews every submission the same day, not an automated process.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.